B. Metzler seel. Sohn & Co. AG Takes Position in Danaher Corporation $DHR

B. Metzler seel. Sohn & Co. AG bought a new stake in Danaher Corporation (NYSE:DHRFree Report) during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm bought 28,281 shares of the conglomerate’s stock, valued at approximately $20,363,000.

Other institutional investors also recently modified their holdings of the company. High Note Wealth LLC increased its position in shares of Danaher by 19.2% during the fourth quarter. High Note Wealth LLC now owns 292 shares of the conglomerate’s stock worth $67,000 after acquiring an additional 47 shares in the last quarter. First Command Advisory Services Inc. grew its stake in shares of Danaher by 4.4% during the 4th quarter. First Command Advisory Services Inc. now owns 1,104 shares of the conglomerate’s stock worth $253,000 after acquiring an additional 47 shares in the last quarter. GW&K Investment Management LLC raised its holdings in shares of Danaher by 8.4% in the fourth quarter. GW&K Investment Management LLC now owns 605 shares of the conglomerate’s stock valued at $138,000 after purchasing an additional 47 shares during the last quarter. Kestra Private Wealth Services LLC lifted its position in shares of Danaher by 0.3% in the third quarter. Kestra Private Wealth Services LLC now owns 15,421 shares of the conglomerate’s stock worth $3,057,000 after purchasing an additional 48 shares in the last quarter. Finally, SOL Capital Management CO boosted its holdings in Danaher by 2.7% during the fourth quarter. SOL Capital Management CO now owns 1,879 shares of the conglomerate’s stock worth $430,000 after purchasing an additional 50 shares during the last quarter. Institutional investors and hedge funds own 79.05% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research firms recently weighed in on DHR. Piper Sandler began coverage on shares of Danaher in a research report on Thursday, June 11th. They issued a “neutral” rating and a $200.00 target price for the company. Guggenheim reduced their price objective on shares of Danaher from $235.00 to $200.00 and set a “buy” rating for the company in a research note on Wednesday, July 22nd. Citigroup began coverage on Danaher in a report on Tuesday, May 26th. They issued a “buy” rating and a $230.00 price objective for the company. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating and issued a $240.00 target price on shares of Danaher in a research report on Wednesday, July 22nd. Finally, Weiss Ratings raised Danaher from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Wednesday, July 15th. One equities research analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and five have issued a Hold rating to the company. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $228.91.

View Our Latest Research Report on DHR

Danaher Stock Up 1.6%

NYSE DHR opened at $219.42 on Friday. The company has a current ratio of 1.65, a quick ratio of 1.25 and a debt-to-equity ratio of 0.48. The company has a market cap of $154.25 billion, a price-to-earnings ratio of 38.97, a PEG ratio of 2.69 and a beta of 0.78. The company has a 50 day moving average of $195.80 and a 200-day moving average of $192.61. Danaher Corporation has a 1-year low of $160.93 and a 1-year high of $242.80.

Danaher (NYSE:DHRGet Free Report) last issued its quarterly earnings results on Monday, July 20th. The conglomerate reported $1.94 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.85 by $0.09. The business had revenue of $6.26 billion for the quarter, compared to the consensus estimate of $6.12 billion. Danaher had a return on equity of 11.04% and a net margin of 15.95%.The firm’s quarterly revenue was up 5.5% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.77 earnings per share. On average, equities research analysts expect that Danaher Corporation will post 8.53 earnings per share for the current fiscal year.

Danaher Profile

(Free Report)

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.

Featured Stories

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHRFree Report).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.